Aries Stern
Psychiatry · Kalamazoo, MINPI 1699833897
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,957 of the $35,207 with a category attached, or 65.2%. 20 manufacturers reported payments, led by AbbVie at 52.7% of the total. Reporting peaked in 2019 at $15,457 and has fallen 79.4% since, to $3,190 in 2025. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $121.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$19K
- Teva Pharmaceuticals USA, Inc.$10K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$809
- E.r. Squibb & Sons, L.L.C.$614
- plus $3K from 14 others
What the payments were for
- Consulting fees$2,4007%
- Speaking & faculty fees$22,95765%
- Travel & lodging$8312%
- Food & beverage$8,66425%
- Education$3551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $18,550 |
| Teva Pharmaceuticals USA, Inc. | 38 | $9,679 |
| Otsuka America Pharmaceutical, Inc. | 41 | $1,318 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $1,230 |
| Alkermes, Inc. | 21 | $809 |
| E.r. Squibb & Sons, L.L.C. | 18 | $614 |
| Axsome Therapeutics, Inc. | 7 | $552 |
| Johnson & Johnson | 10 | $469 |
| Neurocrine Biosciences, Inc. | 6 | $466 |
| Lundbeck LLC | 24 | $463 |
| Vanda Pharmaceuticals Inc. | 17 | $288 |
| Sunovion Pharmaceuticals Inc. | 13 | $255 |
| Jazz Pharmaceuticals Inc. | 2 | $167 |
| Braeburn Inc. | 4 | $136 |
| Corium, LLC | 1 | $79 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Shire North American Group Inc | 2 | $29 |
| Ironshore Pharmaceuticals Inc. | 2 | $28 |
| Merck | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$17,685
- AUSTEDO$8,526
- LYBALVI$895
- CAPLYTA$463
- Auvelity$456
- COBENFY$240
- ABILIFY MAINTENA$228
- ABILIFY ASIMTUFII$228
- INGREZZA$213
- REXULTI$113
- INVEGA SUSTENNA$111
- Fanapt$108
- BRIXADI$106
How this compares
$35,207 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 45 | $25,501 |
| RexultiBrexpiprazole | 12 | $17,703 |
| VraylarCariprazine Hcl | 12 | $17,454 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $11,619 |
| Oxcarbazepine | 18 | $1,825 |
| Metformin Er GastricMetformin Hcl | 14 | $1,281 |
| Atomoxetine Hcl | 14 | $1,098 |
| Bupropion XlBupropion Hcl | 28 | $571 |
| Gabapentin | 28 | $382 |
| Quetiapine Fumarate | 23 | $335 |
| Triazolam | 12 | $288 |
| Hydroxyzine Hcl | 15 | $271 |
| Eszopiclone | 12 | $268 |
| Clonazepam | 15 | $208 |
| Lithium Carbonate | 17 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,318 | $17,70312 claims |
| AbbVieVraylar | $18,550 | $17,45412 claims |
| Axsome Therapeutics, Inc.Auvelity | $552 | $11,61911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in Kalamazoo
- Rajiv TandonKalamazoo$45K
- Nilanjan GajareKalamazoo$22K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.